Cancer Center Amsterdam
-
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism
Huisman, M. C., Pouw, J. E. E., Golla, S. S. V., Huglo, D., Morschhauser, F., Zijlstra, J. M., Wijngaarden, J. E., Stavenga, M., Sebus, H. J., Slebe, M., Thiele, A., Vugts, D., Miedema, I. H. C., Zwezerijnen, G. J. C., Bahce, I., Menke-van der Houven van Oordt, C. W., Shah, D. K., Jauw, Y. W. S. & Boellaard, R., 1 Dec 2025, In: EJNMMI Research. 15, 1, 122.Research output: Contribution to journal › Article › Academic › peer-review
-
Quantification of immuno-PET imaging in cancer
Wijngaarden, J. E., 19 Mar 2025, 207 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
-
Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET
Wijngaarden, J. E., Jauw, Y. W. S., Zwezerijnen, G. J. C., de Wit-van der Veen, B. J., Vugts, D. J., Zijlstra, J. M., van Dongen, G. A. M. S., Boellaard, R., Menke-van der Houven van Oordt, C. W. & Huisman, M. C., 1 Dec 2024, In: EJNMMI Research. 14, 1, 18.Research output: Contribution to journal › Article › Academic › peer-review
- All publications